Biotech | November 12, 2025
Samsung Epis launches new biotech subsidiary Epis NexLab
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Dr. Jindal reflects on bridging accessibility gaps between urban and rural regions, the ethical and emotional aspects of family building, and how initiatives like adoption facilitation centers align with his lifelong mission to help couples realize the dream of parenthood
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies
Subscribe To Our Newsletter & Stay Updated
